Biomerica (NASDAQ:BMRA) Share Price Passes Below 200-Day Moving Average – Here’s What Happened

Biomerica, Inc. (NASDAQ:BMRA) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.47 and traded as low as $0.30. Biomerica shares last traded at $0.33, with a volume of 59,303 shares traded.

Biomerica Stock Down 3.0 %

The firm has a 50 day simple moving average of $0.35 and a 200-day simple moving average of $0.46. The stock has a market cap of $5.01 million, a P/E ratio of -0.80 and a beta of -1.11.

Biomerica (NASDAQ:BMRA) last issued its quarterly earnings results on Tuesday, October 15th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $1.81 million for the quarter. Biomerica had a negative return on equity of 69.21% and a negative net margin of 110.44%.

Institutional Trading of Biomerica

Several institutional investors and hedge funds have recently made changes to their positions in BMRA. Fore Capital LLC boosted its position in Biomerica by 72.1% during the first quarter. Fore Capital LLC now owns 59,680 shares of the company’s stock worth $50,000 after purchasing an additional 25,000 shares during the period. Perritt Capital Management Inc bought a new stake in Biomerica during the second quarter valued at approximately $31,000. Finally, Russell Investments Group Ltd. lifted its position in Biomerica by 11.8% during the first quarter. Russell Investments Group Ltd. now owns 225,435 shares of the company’s stock valued at $188,000 after purchasing an additional 23,872 shares during the last quarter. Hedge funds and other institutional investors own 22.28% of the company’s stock.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.